Skip to content

MOTHER FRİENDLY PRACTİCES AND MATERNAL, FETAL OUTCOMES

THE EFFECTS OF MOTHER FRİENDLY PRACTİCES ON MATERNAL AND FETAL OUTCOMES: A MULTİCENTER STUDY

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07514195
Enrollment
281
Registered
2026-04-07
Start date
2025-02-28
Completion date
2025-09-30
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery Care, Satisfaction With Care

Keywords

Maternal satisfaction, Mother-friendly, Maternal outcomes, Fetal outcomes

Brief summary

The "mother-friendly hospital" model aims to enhance care quality by avoiding unnecessary, non-evidence-based interventions and supporting natural physiological processes from early pregnancy to postpartum. This study evaluated the impact of mother-friendly hospital criteria on labor pain, maternal satisfaction, and maternal and fetal outcomes. Mother-friendly hospital practices emphasizing minimal intervention and physiologic support reduce labor pain, improve maternal satisfaction, and enhance neonatal outcomes. Implementing mother-friendly approaches ensures safe, high-quality, mother-centered maternity care. The results of our study showed that mother-friendly approaches increased maternal satisfaction during the childbirth process and reduced pain scores. These results revealed that mother-friendly practices not only improve the childbirth experience of women but also contribute positively to maternal and neonatal health. Therefore, supporting and expanding the integration of mother-friendly approaches into the healthcare system is of great importance for improving the quality of obstetric services.

Detailed description

This prospective study included term pregnant women delivering between February and June 2025 at Sakarya Research and Training Hospital (Group 1, with mother-friendly practices) and Ümraniye Research and Training Hospital (Group 2, without such practices). Exclusion criteria were maternal age \>45 years, chronic systemic disease, preeclampsia or gestational diabetes, prolonged rupture of membranes with infection, preterm birth (\<37 weeks), and small-for-gestational-age infants (\<2 SD). Maternal characteristics, labor interventions, non-pharmacological methods, postpartum hemorrhage, labor duration, pain levels using the Visual Analog Scale (VAS), and fetal outcomes (birth weight, Apgar scores, NICU admission) were recorded. Maternal satisfaction was assessed in the first postpartum hour using the Birth Satisfaction Scale. A total of 281 women were included (Group 1: 136, Group 2: 145). Groups were similar in age, BMI, education, employment, gestational week, labor duration, and postpartum hemorrhage (p\>0.05). Latent phase, active phase, and postpartum VAS scores were significantly lower in Group 1 (p\<0.001). Maternal satisfaction scores were higher in Group 1 (p\<0.001). NICU admissions were lower in Group 1 (2.9% vs. 9.7%, p=0.022), and first- and fifth-minute Apgar scores were higher (p\<0.001).

Interventions

None listed

Sponsors

Sakarya University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Patients aged 18-45 2. No chronic diseases 3. No acute illnesses 4. No pregnancy complications 5. Spontaneous pregnancy 6. Full-term pregnancy 7. Appropriate-for-gestational-age (AGA) infants

Exclusion criteria

1. Individuals over 45 years of age 2. Maternal type 1 and 2 diabetes mellitus or gestational diabetes 3. Chronic hypertension 4. Preeclampsia 5. Connective tissue disease 6. Smoking during pregnancy 7. Preterm birth (gestational age \<37 weeks) 8. small-for-gestational-age infants (birth weight \< 2 SD) 9. neonatal asphyxia (APGAR score \<7 at 1 and 5 minutes) 10. malformations, chromosomal disorders, and congenital infections 11. women with signs of chorioamnionitis (fever, leukocytosis, abdominal pain, foul-smelling discharge) more than 12 hours after EMR 12. chronic kidney and liver disease 13. hematological disorders 14. Should not be administered to individuals with a pacemaker 15. Should not be administered to patients with epilepsy, transient ischemic attacks, or a history of cerebrovascular events

Design outcomes

Primary

MeasureTime frameDescription
Composite adverse maternal and neonatal outcomeFrom delivery to hospital discharge, 1. dayA composite outcome including at least one of the following: cesarean delivery, postpartum hemorrhage, severe perineal trauma, low 5-minute Apgar score (\<7), or NICU admission.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026